Weighing the Options: An Overview of Weight Loss Medications and Treatment Landscape

Add to Calendar Weighing the Options: An Overview of Weight Loss Medications and Treatment Landscape 5/21/2024 12:00:00 PM 5/21/2024 1:00:00 PM America/New_York For More Details: https://rutgers.cloud-cme.com/course/courseoverview?EID=21713 Description: As per the World Health Organization (WHO), obesity has been classified as an epidemic. According to the U.S. Centers for Disease Control and Prevention, between the years 2017-2020, the prevalence of obesity was estimated at over 40% of the population in the United States. within the last few years, new pharmacologic treatment options for obesity have received approval, which has prompted questions ... false MM/DD/YYYY


Date & Location
Tuesday, May 21, 2024, 12:00 PM - 1:00 PM

Overview
As per the World Health Organization (WHO), obesity has been classified as an epidemic.  According to the U.S. Centers for Disease Control and Prevention, between the years 2017-2020, the prevalence of obesity was estimated at over 40% of the population in the United States.  within the last few years, new pharmacologic treatment options for obesity have received approval, which has prompted questions from both patients and healthcare professionals regarding the optimal use and place in therapy of these medications.  The purpose of this professional continuing education activity is to increase pharmacist knowledge on the significance of the medical condition of obesity and overweight and to ensure pharmacists can accurately identify treatment options for weight loss along with dosing, indication, duration, side effect profile, and proper counseling.

Target Audience
Specialties - General Pharmacy
Professions - Pharmacist

Objectives
  Upon completion of this activity, participants should be better able to:

 


  1. Describe the mechanism of action and pharmacologic effects of FDA-approved weight loss medications.
  2. Explain the efficacy and safety evidence for various pharmacologic options for weight loss according to clinical trial data and adverse event reports.
  3. Describe the incorporation of novel pharmacologic options for weight loss into treatment algorithms to support personalized weight loss management.

Registration
REGISTRATION NOW CLOSED:  You will receive the Virtual Presentation Link the day before this activity.  You must be registered in order to receive the link.  In order to have credit submitted to CPE Monitor on your behalf, you must complete the online evaluation AFTER the activity and BEFORE end-of-day June 5, 2024.  Instructions will be supplied to registrants along with presentation link.

Accreditation and Credit Designation

In support of improving patient care, Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.


Credits
ACPE Credits (1.00 hours)